1 year ago

Petition: Demand Affordable Access to Life-Saving Sickle Cell Treatment

Author Bio

Nicholas Vincent is a passionate environmentalist and freelance writer. He is deeply committed to promoting... Read More

Research scientist working with biological blood samples of a patient in the hematology laboratory. Scientific microbiologist preparing blood smear for analysis under the microscope

A breakthrough treatment has allegedly cured a 21-year-old man’s sickle cell anemia—but its $3.1 million price tag puts it far out of reach for most patients. Lyfgenia, a gene therapy developed by Bluebird Bio, could transform countless lives. But unless the price is dramatically lowered, this revolutionary medicine will remain a luxury for the wealthy, not a lifeline for the many.

Sickle cell disease, affecting mainly Black and Hispanic communities, causes intense pain, organ damage, and early death. The cure exists. Yet, millions still suffer because they can’t afford it.

This is a matter of justice, not just science. Sign the petition now to demand that Bluebird Bio slash the price of Lyfgenia. Urge the FDA to ensure this treatment is accessible to all—not just the privileged few.

Sign the petition now. Lives are on the line.

Sign These Urgent Petitions!

Discover Our Latest Posts

Comments:

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.